Formulation Pharmaceutical Companies Germany
About 2.5 billion euros are spent each year by the GKV for individual cytostatics. Annually, cyto-pharmacies, with a market share of around 80%, produce 4.2 million parenteral oncological preparations - with an increasing trend since the market is confronted with a growing number of patients.
The QnidosMarket Knowledge Study "Recipe Drug Drug Producers" provides executives and decision makers with manufacturers, producers and suppliers the opportunity to gain comprehensive information on the market structures and developments in the manufacturing industries producing cytostatics according to §13 AMG. The focus of the study is on the detailed presentation of current market developments and changes in the area of consolidations, the legal framework, tenders and discount agreements.
The report provides a detailed overview of the market participants and the future development of this market segment.
In addition to the content already described, the study answers the following questions:
What tenders and discount agreements have been made in this product area in recent years? Who are the winners of these calls for tenders?
What are the effects of discounting and tendering on the market?
What are the trends in cost-bearers and legislators?